Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen
- 1 April 1983
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 302 (5908) , 490-495
- https://doi.org/10.1038/302490a0
Abstract
Potential live vaccines against hepatitis B virus have been produced. The coding sequence for hepatitis B virus surface antigen (HBsAg) has been inserted into the vaccinia virus genome under control of vaccinia virus early promoters. Cells infected with these vaccinia virus recombinants synthesize and excrete HBsAg and vaccinated rabbits rapidly produce antibodies to HBsAg.This publication has 31 references indexed in Scilit:
- Vaccinia virus: a selectable eukaryotic cloning and expression vector.Proceedings of the National Academy of Sciences, 1982
- Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.Proceedings of the National Academy of Sciences, 1982
- Molecular genetics of vaccinia virus: demonstration of marker rescue.Proceedings of the National Academy of Sciences, 1982
- Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNAProceedings of the National Academy of Sciences, 1982
- Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus geneCell, 1981
- Expression of poxvirus DNA in coinfected cells and marker rescue of thermosensitive mutants by subgenomic fragments of DNAAnnales de l'Institut Pasteur / Virologie, 1981
- Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigenNature, 1979
- Cloning in Escherichia coli and physical structure of hepatitis B virion DNA.Proceedings of the National Academy of Sciences, 1979
- Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322Nature, 1979
- Cloning and endonuclease mapping of the hepatitis B viral genomeNature, 1979